A physician group said that it had developed a new ethics code, to reduce the influence that pharmaceutical and medical devices companies have over physicians and patients.
The code focuses on seven points, ranging from financial disclosure to conflicts of interest. The group behind the new code, the Council of Medical Specialty Societies, represents 32 medical societies, which in turn represent 650,000 physicians in the US.
Of interest to the PR industry, the code noted that medical societies should develop education and advocacy program independent of private healthcare companies.
The Associates Press writes:
It's the most sweeping move ever taken by the Council of Medical Specialty Societies to curb conflict of interest -- a growing concern as private industry bankrolls a greater share of medical research.